Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial protocol.

Thomas LJ, Abel A, Ridgway N, Peters T, Kessler D, Hollinghurst S, Turner K, Garland A, Jerrom B, Morrison J, Williams C, Campbell J, Kuyken W, Lewis G, Wiles N.

Contemp Clin Trials. 2012 Mar;33(2):312-9. doi: 10.1016/j.cct.2011.10.016. Epub 2011 Nov 11.

PMID:
22101205
2.

Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.

Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, Sherlock S, Turner N, Button K, Odondi L, Metcalfe C, Owen-Smith A, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G.

Health Technol Assess. 2014 May;18(31):1-167, vii-viii. doi: 10.3310/hta18310.

3.

Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial.

Wiles N, Thomas L, Abel A, Ridgway N, Turner N, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G.

Lancet. 2013 Feb 2;381(9864):375-84. doi: 10.1016/S0140-6736(12)61552-9. Epub 2012 Dec 7.

PMID:
23219570
4.

Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial.

Hollinghurst S, Carroll FE, Abel A, Campbell J, Garland A, Jerrom B, Kessler D, Kuyken W, Morrison J, Ridgway N, Thomas L, Turner K, Williams C, Peters TJ, Lewis G, Wiles N.

Br J Psychiatry. 2014 Jan;204(1):69-76. doi: 10.1192/bjp.bp.112.125286. Epub 2013 Nov 21. Erratum in: Br J Psychiatry. 2014 Mar;204(3):245.

5.

Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.

Tallon D, Wiles N, Campbell J, Chew-Graham C, Dickens C, Macleod U, Peters TJ, Lewis G, Anderson IM, Gilbody S, Hollingworth W, Davies S, Kessler D.

Trials. 2016 Feb 3;17:66. doi: 10.1186/s13063-016-1199-2.

6.

Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.

Wiles NJ, Thomas L, Turner N, Garfield K, Kounali D, Campbell J, Kessler D, Kuyken W, Lewis G, Morrison J, Williams C, Peters TJ, Hollinghurst S.

Lancet Psychiatry. 2016 Feb;3(2):137-44. doi: 10.1016/S2215-0366(15)00495-2. Epub 2016 Jan 7.

7.

Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.

Button KS, Turner N, Campbell J, Kessler D, Kuyken W, Lewis G, Peters TJ, Thomas L, Wiles N.

J Affect Disord. 2015 Mar 15;174:272-80. doi: 10.1016/j.jad.2014.11.057. Epub 2014 Dec 6.

PMID:
25527998
9.

Effectiveness of cognitive behavioural therapy augmentation in major depression treatment (ECAM study): study protocol for a randomised clinical trial.

Nakagawa A, Sado M, Mitsuda D, Fujisawa D, Kikuchi T, Abe T, Sato Y, Iwashita S, Mimura M, Ono Y.

BMJ Open. 2014 Oct 21;4(10):e006359. doi: 10.1136/bmjopen-2014-006359.

10.

Physical activity as a treatment for depression: the TREAD randomised trial protocol.

Baxter H, Winder R, Chalder M, Wright C, Sherlock S, Haase A, Wiles NJ, Montgomery AA, Taylor AH, Fox KR, Lawlor DA, Peters TJ, Sharp DJ, Campbell J, Lewis G.

Trials. 2010 Nov 12;11:105. doi: 10.1186/1745-6215-11-105.

11.

Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.

Serfaty MA, Haworth D, Blanchard M, Buszewicz M, Murad S, King M.

Arch Gen Psychiatry. 2009 Dec;66(12):1332-40. doi: 10.1001/archgenpsychiatry.2009.165.

PMID:
19996038
12.

Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial.

Watanabe N, Horikoshi M, Yamada M, Shimodera S, Akechi T, Miki K, Inagaki M, Yonemoto N, Imai H, Tajika A, Ogawa Y, Takeshima N, Hayasaka Y, Furukawa TA; Steering Committee of the Fun to Learn to Act and Think through Technology Project.

Trials. 2015 Jul 7;16:293. doi: 10.1186/s13063-015-0805-z.

13.

Clinical and cost-effectiveness of computerised cognitive behavioural therapy for depression in primary care: design of a randomised trial.

de Graaf LE, Gerhards SA, Evers SM, Arntz A, Riper H, Severens JL, Widdershoven G, Metsemakers JF, Huibers MJ.

BMC Public Health. 2008 Jun 30;8:224. doi: 10.1186/1471-2458-8-224.

14.

Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost-effectiveness and value of information analyses.

Stevenson MD, Scope A, Sutcliffe PA, Booth A, Slade P, Parry G, Saxon D, Kalthenthaler E; group cognitive behavioural therapy for postnatal depression advisory group.

Health Technol Assess. 2010 Sep;14(44):1-107, iii-iv. doi: 10.3310/hta14440. Review.

15.

Effectiveness and cost effectiveness of cognitive behavioral therapy (CBT) in clinically depressed adolescents: individual CBT versus treatment as usual (TAU).

Stikkelbroek Y, Bodden DH, Deković M, van Baar AL.

BMC Psychiatry. 2013 Nov 21;13:314. doi: 10.1186/1471-244X-13-314.

16.

The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.

McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M.

Health Technol Assess. 2007 Jul;11(24):1-54.

17.

A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial.

Sharp DJ, Chew-Graham C, Tylee A, Lewis G, Howard L, Anderson I, Abel K, Turner KM, Hollinghurst SP, Tallon D, McCarthy A, Peters TJ.

Health Technol Assess. 2010 Sep;14(43):iii-iv, ix-xi, 1-153. doi: 10.3310/hta14430.

18.

Cost-effectiveness of cognitive behaviour therapy versus talking and usual care for depressed older people in primary care.

Holman AJ, Serfaty MA, Leurent BE, King MB.

BMC Health Serv Res. 2011 Feb 11;11:33. doi: 10.1186/1472-6963-11-33.

19.

Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders.

Köhler S, Hoffmann S, Unger T, Steinacher B, Dierstein N, Fydrich T.

Clin Psychol Psychother. 2013 Mar-Apr;20(2):97-106. doi: 10.1002/cpp.795. Epub 2011 Nov 17.

PMID:
22095701
20.

Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.

Segal ZV, Bieling P, Young T, MacQueen G, Cooke R, Martin L, Bloch R, Levitan RD.

Arch Gen Psychiatry. 2010 Dec;67(12):1256-64. doi: 10.1001/archgenpsychiatry.2010.168.

Items per page

Supplemental Content

Write to the Help Desk